Tournament: Byram Hills | Round: 2 | Opponent: Sam Hadiono | Judge: Tracy Brown
IPP reductions promote counterfeit medicines and access is meaningless without quality medicine
Lybecker, Kristina. Associate Professor of Economics at Colorado College “Counterfeit Medicines and the Role of IP in Patient Safety.” IPWatchDog, 2016. https://www.ipwatchdog.com/2016/06/27/counterfeit-medicines-ip-patient-safety/id=70397/ CS
The threat of counterfeit goods took center stage on June 15th in a hearing convened by Senate Finance Committee Chairman Orrin Hatch (R-Utah).
AND
To truly address the access problem, we must move beyond blaming IPRs and begin the difficult work of grappling with structural deficiencies and poverty.
NEXT
Counterfeit medicines are a global public health issue and must be prevented by legal protection
Brezovska, Katerina. Ss. Cyril and Methodius University in Skopje “Counterfeiting of medicines as an infringement of the intellectual property rights.” Research Gate, 2016.https://www.researchgate.net/publication/332638896_Counterfeiting_of_medicines_as_an_infringement_of_the_intellectual_property_rights//CS
Counterfeiting and piracy are one of the biggest issues of the global economy
AND
The role of the pharmaceutical manufacturers, wholesalers and retailers in the fight against counterfeited medicines is essential for both securing the supply chain to provide quality, safety and efficacy of the medicines that reach the patients from one side and to protecting their brands and their profit from the other side.
NEXT
Only IPRs can check back against counterfeit production – key to solving crisis
FIFARMA 4/28. “This Is How We Fight Counterfeit Medicines with Intellectual Property.” FIFARMA, 28 Apr. 2021, fifarma.org/en/this-is-how-we-fight-counterfeit-medicines-with-intellectual-property/.
This is how we fight counterfeit medicines with Intellectual Property
AND
exist, the important